GL1X · GenesisL1 explorer

Research workbench

Crystal structure of daratumumab Fab and CD38 complex

Analyse Crystal structure of daratumumab Fab and CD38 complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7DUO
Type
protein
Length
652 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab heavy chain; ADP-ribosyl CYCLASE/CYCLIC ADP-ribose hydrolase 1; Fab light chain
EC
3.2.2.6, 2.4.99.20
UniProt
P28907
Pockets
8 · best druggability 0.62

Structure

x-ray diffraction · 3 distinct chains · 20% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HFab heavy chainprotein2108% helix, 49% strand—
BADP-ribosyl CYCLASE/CYCLIC ADP-ribose hydrolase 1 (EC 3.2.2.6, 2.4.99.20)protein22944% helix, 13% strandP28907
LFab light chainprotein2136% helix, 51% strand—

Pockets

8 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15660.620.7460empty
21810.590.8131empty
33110.570.7637empty
41660.570.8129empty
5620.460.8423empty

Interfaces

3 interfaces between chains.

  • H–L · 1719 Ų buried · 17 hydrogen bonds · protein-protein
  • H–B · 675 Ų buried · 12 hydrogen bonds · protein-protein
  • B–L · 175 Ų buried · 2 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 7DUO · Crystal structure of daratumumab fab and CD38 complex · the same entry in another collection · chain H against H, TM-score 1.00
  • P28907 · AlphaFold monomer V2.0 prediction for ADP-ribosyl CYCLASE/CYCLIC ADP- ribose hydrolase 1… · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.